ChemicalBook > CAS DataBase List > Enocitabine

Enocitabine

Product Name
Enocitabine
CAS No.
55726-47-1
Chemical Name
Enocitabine
Synonyms
BH-AC;CS-1807;SUNRABIN;NSC-239336;ENOCITABINE;Enocitabine API;BEHENOYLCYTOSINE ARABINOSIDE;N4-Behenoylcytosine arabinoside;n(sup4)-behenoylcytosinearabinoside;ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS
CBNumber
CB3266605
Molecular Formula
C31H55N3O6
Formula Weight
565.78
MOL File
55726-47-1.mol
More
Less

Enocitabine Property

Melting point:
141-142°C
alpha 
D +70° (c = 1 in THF, 22°)
Boiling point:
630.87°C (rough estimate)
Density 
1.0967 (rough estimate)
refractive index 
1.7800 (estimate)
storage temp. 
Keep in dark place,Sealed in dry,Store in freezer, under -20°C
solubility 
DMSO (Slightly, Heated), Methanol (Slightly, Heated), THF (Slightly, Heated, Soncited)
pka
10.14±0.20(Predicted)
form 
Solid
color 
White to Off-White
CAS DataBase Reference
55726-47-1(CAS DataBase Reference)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
E557500
Product name
Enocitabine
Packaging
10mg
Price
$90
Updated
2021/12/16
Usbiological
Product number
296092
Product name
Enocitabine
Packaging
5mg
Price
$462
Updated
2021/12/16
Biosynth Carbosynth
Product number
NE05152
Product name
Enocitabine
Packaging
100mg
Price
$500
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0002546
Product name
ENOCITABINE
Purity
95.00%
Packaging
100MG
Price
$1593.9
Updated
2021/12/16
ChemScene
Product number
CS-0082897
Product name
Enocitabine
Purity
≥98.0%
Packaging
10mg
Price
$680
Updated
2021/12/16
More
Less

Enocitabine Chemical Properties,Usage,Production

Description

Enocitabine (NSC-239336, BHAC) is an antileukemic agent closely related to cytarabine. It appears more resistant to deamination than cytarabine, thus allowing greater in vivo phosphorylation into an active cytotoxic metabolite. Enocitabine is lipophilic, but the drug does not enter the cerebrospinal fluid and is concentrated in the bone marrow and red blood cells. It can be administered orally and appears to be more effective than the parent compound in preclinical models.

Chemical Properties

Crystalline Solid

Originator

Asahi (Japan)

Uses

An antineoplastic. A derivative of Cytarabine.

Definition

ChEBI: Enocitabine is an organic molecular entity.

brand name

SUNRABIN

Enocitabine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Enocitabine Suppliers

Carbosynth Limited
Tel
--
Fax
--
Email
sales@carbosynth.com
Country
United Kingdom
ProdList
6581
Advantage
61
Leancare Ltd.
Tel
--
Fax
--
Email
enquiry@leancare.co.uk
Country
United Kingdom
ProdList
6446
Advantage
42
CARBONE SCIENTIFIC CO.,LTD
Tel
--
Fax
--
Email
sales@carbonesci.com
Country
United Kingdom
ProdList
6666
Advantage
30
Eurolabs Limited
Tel
--
Fax
--
Country
United Kingdom
ProdList
6309
Advantage
46
ETA SCIENTIFIC Co.,Ltd
Tel
--
Fax
--
Email
sales@etascientific.com
Country
United Kingdom
ProdList
6090
Advantage
34
UK GREEN SCIENTIFIC CO.,LIMITED
Tel
--
Fax
--
Email
sales@gs-chem.com
Country
United Kingdom
ProdList
6098
Advantage
47
Apin Chemicals Ltd.
Tel
--
Fax
--
Email
info@apinchemicals.com
Country
United Kingdom
ProdList
6807
Advantage
42
Sequoia Research Products Ltd.
Tel
--
Fax
--
Email
sales@seqchem.com
Country
United Kingdom
ProdList
3113
Advantage
69
More
Less

View Lastest Price from Enocitabine manufacturers

Beijing Yibai Biotechnology Co., Ltd
Product
Enocitabine 55726-47-1
Price
US $0.00-0.00/KG
Min. Order
1g
Purity
99.0%
Supply Ability
50kg/month
Release date
2019-08-28
Career Henan Chemical Co
Product
Enocitabine 55726-47-1
Price
US $1.00/KG
Min. Order
1IU
Purity
99%
Supply Ability
100kg
Release date
2019-12-24

55726-47-1, EnocitabineRelated Search:


  • N-(1-BETA-D-ARABINOFURANOSYL-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)DOCOSANAMIDE
  • NSC-239336
  • SUNRABIN
  • BEHENOYLCYTOSINE ARABINOSIDE
  • BH-AC
  • ENOCITABINE
  • CS-1807
  • 1-benzimidazolyl-(5-bromo-2-furanyl)methanone
  • n-(1-beta-d-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-docosanamid
  • n(sup4)-behenoyl-1-beta-d-arabinofuranosylcytosine
  • n(sup4)-behenoylcytosinearabinoside
  • N-[1-[(2R,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-pyrimidin-4-yl]docosanamide
  • 1-β-D-Arabinofuranosyl-4-(1-oxodocosyl)amino-1,2-dihydropyrimidin-2-one
  • Enocitabine API
  • N-(1-B-D-Arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide, Behenoylcytosine Arabinoside, BH-AC, NSC-239336, Sunrabin
  • Docosanamide, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
  • N4-Behenoyl-1-β-D-arabinofuranosylcytosine
  • N4-Behenoylcytosine arabinoside
  • N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide
  • ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS
  • N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide Enocitabine
  • N(4)-behenoyl-1-beta-arabinofuranosylcytosine
  • N-(1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide
  • Inhibitor,CMV,Enocitabine,inhibit,DNA/RNA Synthesis,Sunrabin,Cytomegalovirus,AML,acute myelogenous leukaemia,Nucleoside Antimetabolite/Analog
  • N-{1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}docosanamide
  • Docosanamide,N-(1-b-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
  • 55726-47-1
  • C31H55N3O6
  • Intermediates & Fine Chemicals
  • Pharmaceuticals